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Uropathogenic Escherichia coli Superinfection Enhances
the Severity of Mouse Bladder Infection
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1 Department of Molecular Microbiology, Center for Women’s Infectious Disease Research, Washington University in St. Louis, St. Louis, Missouri, United States of America,
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Abstract
Urinary tract infections (UTIs) afflict over 9 million women in America every year, often necessitating long-term prophylactic
antibiotics. One risk factor for UTI is frequent sexual intercourse, which dramatically increases the risk of UTI. The mechanism
behind this increased risk is unknown; however, bacteriuria increases immediately after sexual intercourse episodes,
suggesting that physical manipulation introduces periurethral flora into the urinary tract. In this paper, we investigated
whether superinfection (repeat introduction of bacteria) resulted in increased risk of severe UTI, manifesting as persistent
bacteriuria, high titer bladder bacterial burdens and chronic inflammation, an outcome referred to as chronic cystitis.
Chronic cystitis represents unchecked luminal bacterial replication and is defined histologically by urothelial hyperplasia and
submucosal lymphoid aggregates, a histological pattern similar to that seen in humans suffering chronic UTI. C57BL/6J mice
are resistant to chronic cystitis after a single infection; however, they developed persistent bacteriuria and chronic cystitis
when superinfected 24 hours apart. Elevated levels of interleukin-6 (IL-6), keratinocyte cytokine (KC/CXCL1), and
granulocyte colony-stimulating factor (G-CSF) in the serum of C57BL/6J mice prior to the second infection predicted the
development of chronic cystitis. These same cytokines have been found to precede chronic cystitis in singly infected C3H/
HeN mice. Furthermore, inoculating C3H/HeN mice twice within a six-hour period doubled the proportion of mice that
developed chronic cystitis. Intracellular bacterial replication, regulated hemolysin (HlyA) expression, and caspase 1/11
activation were essential for this increase. Microarrays conducted at four weeks post inoculation in both mouse strains
revealed upregulation of IL-1 and antimicrobial peptides during chronic cystitis. These data suggest a mechanism by which
caspase-1/11 activation and IL-1 secretion could predispose certain women to recurrent UTI after frequent intercourse, a
predisposition predictable by several serum biomarkers in two murine models.
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increasingly being treated with fluoroquinolones, which in turn
has led to a rise in resistance and the spread of multi-drug resistant
microorganisms globally, which is a looming worldwide crisis
[16,17]. It is therefore imperative to understand the molecular
mechanisms that underlie this problematic disease in order to
develop novel therapies.
Sexual intercourse is one of the most significant risk factors
predisposing otherwise healthy women to UTI. Early studies
demonstrated that sexual intercourse led to a 10-fold increase in
bacteria/ml of urine and a subsequently increased predisposition
to developing a UTI within 24 hours thereafter [5,18–21]. More
recent studies have shown that the frequency with which a woman
has sexual intercourse dramatically impacts the likelihood of
developing both acute and rUTI [4,22,23]. Scholes et. al found a
direct association between the number of episodes of sexual
intercourse in a given month and the risk of developing rUTI.
However the significance of the timing between these episodes of
sexual intercourse is unknown. Are evenly spaced episodes
associated with an equal risk or, instead, does an episode prime

Introduction
Nearly nine million people present each year to primary care
physicians with a urinary tract infection (UTI), costing nearly $2
billion yearly [1,2]. Women suffer the majority of these infections,
with the lifetime risk approaching 50% [3]. Furthermore, 25–40%
of these women will suffer recurrent UTI (rUTI), with 1.5 million
women referred to urology clinics and often requiring prophylactic
antibiotics to prevent recurrence [4–6]. Uropathogenic E. coli
(UPEC) are responsible for.80% of community acquired UTI
and 50% of nosocomial UTI [7,8]. In the absence of antibiotic
therapy, up to 60% of women experience symptoms and/or
bacteriuria lasting months after initial infection [9–12], implying
that cystitis is not always self-limiting. Furthermore, if the infection
persists without adequate treatment, the organisms have the
capacity to ascend the ureters, causing pyelonephritis and sepsis
[13]. Antibiotic resistant organisms further complicate infection
and threaten to increase the likelihood of chronic UTI,
pyelonephritis and potentially bacteremia [14,15]. UTIs are
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bacteriuria (.104 CFU/ml) and high titer bacterial bladder
burdens (.104 CFU) two or more weeks after inoculation,
accompanied by chronic inflammation [37,39], or resolution of
bacteriuria [37]. Mice that resolve infection may harbor small
populations of dormant UPEC called Quiescent Intracellular
Reservoirs (QIRs) [40]. Other mouse strains exhibit varied
proportions of these two outcomes. C57BL/6J mice resolve
bacteriuria within days and thus are resistant to chronic cystitis,
but are susceptible to QIR formation [40,41]. In contrast, other
TLR4-responsive C3H background sub-strains and closely
related CBA/J and DBA/2J mice experience persistent hightiter bacteriuria and bladder colonization by UPEC in the
presence of chronic inflammation lasting at least four weeks postinfection (wpi). During chronic cystitis, persistent lymphoid
aggregates and urothelial hyperplasia with lack of superficial
facet cell terminal differentiation accompany luminal bacterial
replication [37]. These same histological findings of submucosal
lymphoid aggregates and urothelial hyperplasia have been
observed in humans suffering persistent bacteriuria and chronic
cystitis [42]. Since murine chronic cystitis predisposes to
recurrent chronic UTI after antibiotic-mediated bacterial clearance, this is also a relevant model to interrogate the mechanism
of recurrent cystitis [37]. In mouse models of UTI, mice initially
experience urinary frequency and dysuria as determined by
reaction to noxious stimuli and nerve responses during acute
infection [43,44]; however, during chronic cystitis bacterial
replication may exist in an asymptomatic carrier state as studies
have not been conducted to determine whether dysuria persists.
Interestingly, higher serum levels of interleukins (IL) 5 and 6,
keratinocyte cytokine (KC/CXCL1), and granulocyte colonystimulating factor (G-CSF) in C3H/HeN mice at 24 hours post
infection (hpi) predicted the development of persistent bacteriuria
and chronic cystitis thereafter, suggestive of a host-pathogen
checkpoint during acute infection that predicts long term
outcome [26,37]. In women with an acute UTI, increased
amounts of serum CXCL1, M-CSF, and IL-8 correlated with
subsequent rUTI, suggesting a similar checkpoint [45].
In this manuscript, we developed a superinfection model to
mimic the clinical scenario of frequent sexual intercourse
whereby sequential inocula are introduced within a brief period
of time. C57BL/6J mice are resistant to chronic cystitis when
singly infected; however, 30% of C57BL/6J mice developed
chronic cystitis when superinfected 24 hours after the initial
infection. Serum elevations of IL-6, KC, and G-CSF prior to
superinfection predicted the development of persistent bacteriuria
in C57BL/6J mice similar to singly infected C3H/HeN mice.
Superinfecting C3H/HeN mice 1–6 hours after the initial
inoculation increased the proportion of mice experiencing
chronic cystitis. In order for this elevation to occur, we found
that the initial UPEC inoculum (the ‘‘priming’’ inoculation) must
be alive, invasive, capable of intracellular replication, and able to
regulate hemolysin expression. Inhibition of the caspase 1/11
inflammasome prior to priming reduced bacterial CFU at four
wpi relative to DMSO-treated mice. Microarray analysis of
mouse bladders four wpi revealed that both C57BL/6J and
C3H/HeN mice secreted antimicrobial peptides and IL-1 during
chronic infection. In contrast to C3H/HeN mice, immunoglobulin expression was upregulated in C57BL/6J mice experiencing
chronic cystitis. This immunoglobulin expression was absent in
C57BL/6J mice that resolved infection and in C3H/HeN mice.
Our data suggest mechanisms whereby certain women may be
susceptible to rUTI after frequent sexual intercourse dependent
on intracellular bacterial replication and the host immune
response.

Author Summary
Urinary tract infections (UTIs) affect millions of women
each year resulting in substantial morbidity and lost
wages. Approximately 1.5 million women are referred to
urology clinics suffering from chronic recurrent UTI on a
yearly basis necessitating the use of prophylactic antibiotics. Frequent and recent sexual intercourse correlates with
the development of UTI, a phenomenon referred to
clinically as ‘‘honeymoon cystitis.’’ Here, using superinfection mouse models, we identified bacterial and host
factors that influence the likelihood of developing chronic
UTI. We discovered that superinfection leads to a higher
rate of chronic UTI, which depended on bacterial replication within bladder cells combined with an immune
response including inflammasome activation and cytokine
release. These data suggest that bacterial inoculation into
an acutely inflamed urinary tract is more likely to lead to
severe UTI than bacterial presence in the absence of
inflammation. Modification of these risk factors could lead
to new therapeutics that prevent the development of
recurrent UTI.

the bladder for rUTI if another insult follows within a sensitive
period? To address this question, we developed a model of
sequential infection in mice to explore the hypothesis that a
sensitive period exists after an initial bacterial insult to the bladder
in which the likelihood of developing severe, chronic infection is
dramatically increased.
Murine models of UTI have been used to decipher complexities
of this disease in naı̈ve individuals. UPEC are capable of
colonizing multiple body habitats and niches, including both
intracellular and extracellular locations within the bladder, as well
as in the gastrointestinal (GI) tract and the kidneys. Selective
pressure and bacterial population bottlenecks during colonization
impact the ultimate fate of disease [24–27]. Adhesive pili
assembled by the chaperone/usher pathway (CUP), such as type
1 pili, contain adhesins at their tips that function in adherence and
invasion of host tissues and in biofilm formation on medical
devices. Upon introduction of UPEC into the bladder, bacteria
bind to either mannosylated uroplakin plaques or b1-a3 integrin
receptors on the epithelial surface of the bladder via the type 1
pilus FimH adhesin [28–30]. Upon internalization, UPEC can be
exocytosed as part of a TLR4 dependent innate defense process
[31]. In addition to expulsion of individual bacteria, the host can
exfoliate superficial facet cells to shed attached and invaded
bacteria into the urine for clearance [29]. A small fraction of
invaded bacteria escape into the host cell cytoplasm, where they
are able to subvert expulsion and innate defenses by replicating
into biofilm-like intracellular bacterial communities (IBCs) [24,32].
UPEC eventually flux out of these communities with a substantial
proportion existing as neutrophil resistant filaments [33,34].
Importantly, evidence of IBCs and bacterial filaments have been
observed in women suffering acute UTI, one to two days post selfreported sexual intercourse, but not in healthy controls or
infections caused by Gram-positive organisms, which do not form
IBCs [21]. IBCs have also been observed in urine from children
with an acute UTI [35]. Additionally, IBC formation and the
innate immune response of cytokine secretion and exfoliation have
been observed in all tested mouse strains, but the long-term
outcome of infection differs [36–38].
There are two main, mutually exclusive, outcomes to acute
infection in C3H/HeN mice: either chronic bacterial cystitis
(chronic cystitis), which is characterized by persistent high titer
PLOS Pathogens | www.plospathogens.org

2

January 2015 | Volume 11 | Issue 1 | e1004599

Superinfection Enhances Severe Bladder Infection

24 hpi had no effect on bacterial titers at one week, suggesting that
the factors predisposing to increased susceptibility to chronic
cystitis upon superinfection wane over time [26]. However,
inoculation with PBS followed by UTI89 24 hpi did lead to high
titers in 60% of mice. While this result is perplexing, it possibly
reflects that sacrifice six days post infection was not sufficient to
delineate the typical bimodal distribution of outcomes [37]. The
process of catheterization also induces inflammation, which may
not have resolved by 6 dpi [46]. We conducted all subsequent
C3H/HeN superinfections one hour after priming.
Since early severe inflammatory responses predispose to chronic
cystitis [37], we hypothesized that the initial inoculum primed the
bladder by initiating an innate immune response to intracellular
bacteria that predisposed to a higher proportion of mice
experiencing chronic cystitis upon superinfection. We utilized a
panel of UTI89 mutants in fimH, ompA, and kps that have been
shown to differ in their ability to: i) invade and form IBCs and ii)
persist during chronic cystitis in co-infection experiments [47,48].
Mature IBCs caused by WT bacteria are clonally derived from a
single invasive event [24]. The mannose-binding pocket of FimH

Results
Time-sensitive enhancement of infection
Studies suggest that a host-pathogen checkpoint within the first
24 hpi determines UTI outcome in C3H/HeN mice [26,37]. In
addition, the chronic inflammation observed in mice experiencing
chronic cystitis was found to predispose to rUTI after re-infection
[37]. Thus, we hypothesized that superinfecting mice during this
period of acute inflammation would increase the proportion of
mice experiencing chronic cystitis. We transurethrally infected 7–
8 week old female C3H/HeN mice with 107 CFU UTI89 or PBS
as the priming inoculation and superinfected them 1–2, 6, or
24 hours thereafter. Enumeration of bacterial CFU at one wpi as
an initial screen revealed a dramatic increase in the proportion of
mice experiencing chronic cystitis in mice superinfected 1–6 hours
after priming compared to singly infected or PBS treated mice
(Fig. 1A). We used a cutoff of 106 CFU to demarcate mice
experiencing high-titer bacterial infection at one week. Importantly, we did not observe a significant increase in CFU when a
single inoculum was doubled (26107 CFU). Superinfection at

Fig. 1. Superinfections of C3H/HeN mice. A) Mice were infected with 107 CFU UTI89, 26107 CFU UTI89, or PBS and re-infected with UTI89 at the
indicated time points. One week total bladder titers are shown. Percentage of mice likely to develop chronic cystitis is displayed at the top of the
column based on a CFU cutoff of 106. Asterisks indicate p,0.05 from the PBS control and singly infected mice. B–D) Mice were infected with the
indicated strain or PBS and re-infected one hour later. Urine titers were determined over time and four-week bladder titers are displayed. The fraction
of mice with chronic cystitis is displayed at the top of each column. Red data points indicate resolved infection. Horizontal bars indicate median
values. The dashed line at 20 CFU represents the LOD, and the dashed line at 106 (A) or 104 CFU (B–D) represents the chronic cystitis cutoff for urine
and bladder titers. Panel A reflects 2–4 experiments with 5–9 mice per group. Panel B is 2–7 experiments with 4–5 mice per group. Panel C–D are 3
experiments with 4–5 mice per group. Statistical comparisons were determined using Fisher’s exact test based on the fraction of mice experiencing
chronic cystitis.
doi:10.1371/journal.ppat.1004599.g001
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inflammatory response. Interestingly, in C3H/HeN mice, UTI89
DhlyA is not attenuated throughout infection and causes chronic
cystitis comparable to UTI89; however, other reports suggest
deletion of HlyA in UPEC CFT073 decreases virulence [54]. We
investigated the role of hemolysin in priming the bladder for
chronic cystitis upon superinfection by utilizing UTI89DhlyA or
UTI89DcpxR as the initial inoculation followed by WT UTI89
one hpi. Both of these strains were statistically significantly
different when compared to WT UTI89 as the priming inoculum.
Therefore, we conclude that neither was capable of priming the
bladder for enhanced chronic cystitis (Fig. 1D). Thus, too high or
low expression of hemolysin abolished the ability of UTI89 to
prime for enhanced chronic cystitis implying that an optimal level
of hemolysin expression is critical for priming the bladder for
enhanced chronic cystitis.
HlyA-mediated exfoliation is in part due to its ability to trigger
degradation of paxillin, a scaffold protein that modulates the
dynamics of cytoskeletal rearrangements [55]. HlyA can also
trigger cell death in human bladder epithelial cells and release of
IL-1a via caspase-4 (the murine ortholog is caspase-11) activation
and caspase-1-dependent IL-1b secretion via activation of the
NLRP3 inflammasome pathway, which orchestrates additional
cell death (Nagamatsu et al. in review). We hypothesized that
inflammasome and caspase 1/11 activation were essential for
superinfection. Thus, mice were treated intravesically with a dose
of caspase 1/11 inhibitor or DMSO one hour prior to priming and
a second dose with the priming inoculum to test this hypothesis
(Fig. 2A). Providing two doses of the inhibitor was previously
shown to be effective in dampening in vivo inflammatory
responses. In vitro, the inhibitor dramatically reduced downstream
elements of inflammasome activation, IL-1a and IL-1b secretion,
when bladder cells were infected with UTI89 (Nagamatsu et al. in
review). Caspase 1/11 inhibition significantly reduced median
bladder titers at four weeks after superinfection relative to the
DMSO control group (Fig. 2B). We also saw a trend of caspase 1/
11 inhibition in reducing the proportion of WT superinfected mice
experiencing chronic cystitis to single infection levels (Fig. 2B).
DMSO also reduced the proportion of mice experiencing
persistent bacteriuria and chronic cystitis, but to a lesser degree
than caspase 1/11 inhibition (Fig. 2B vs. Fig. 1B–D), suggesting
an anti-inflammatory role of DMSO alone. Intriguingly, DMSO
was recently found to inhibit the NLRP3 inflammasome [56].
Taken together, these data implicate hemolysin and the NLRP3
inflammasome in the priming response to enhanced chronic
cystitis.
We further investigated whether chemical exfoliation could
enhance the proportion of mice experiencing chronic cystitis prior
to a single infection. We utilized the cationic protein, protamine
sulfate, which has previously been used to exfoliate the superficial
facet cell layer of the urothelium [40,57]. A 10 mg/mL dose
delivered intravesically in 50 mL PBS was shown to exfoliate 65%
of the facet cell layer 12 hours after treatment while an additional
booster dose of 50 mg/mL led to 95% exfoliation [40]. We
utilized these concentrations to initiate, but likely not complete,
the process of exfoliation one hour prior to infection with UTI89.
We did not observe a significant increase in the proportion of mice
experiencing chronic cystitis over PBS pretreatment (Fig. 2C).
Thus, these data suggest that at least partial IBC formation in
conjunction with caspase 1/11 activation primes the bladder for
enhanced chronic cystitis, but chemical initiation of exfoliation is
not sufficient. Taken together, these data suggest that exfoliation
per se might not play a significant role in impacting the likelihood
of enhanced chronic cystitis but instead may reflect a downstream
marker of the priming event.

is invariant among sequenced UPEC [47], and the binding
pocket mutant, FimH::Q133K, is defective in mannose-binding
and can neither invade the bladder epithelium nor form IBCs.
FimH undergoes compact and elongated conformational changes wherein the receptor binding domain bends approximately
37u with respect to the pilin domain. The mannose-binding
pocket is deformed in the compact conformation whereas the
elongated conformation is mannose binding proficient [49,50].
Several residues outside the mannose-binding pocket (positions
27, 62, 66 and 163) are under positive selection in clinical UPEC
isolates compared to fecal strains [47] and have been shown to
function in modulating the conformational changes between the
elongated and compact states [48]. FimH::A27V/V163A predominantly adopts a high-mannose binding, elongated conformation. Its expression results in: i) a 10-fold reduction in
intracellular CFU one hpi and ii) a defect in the ability to form
IBCs at six hpi. FimH::A62S shifts the equilibrium towards the
compact conformation. Expression of this allele results in: i) a 10fold reduction in intracellular CFU one hpi and ii) a 10-fold
reduction in IBC formation compared to WT UTI89 [47,48].
UTI89DompA forms half the number of IBCs as UTI89 [51],
and UTI89Dkps is defective in IBC formation. UTI89Dkps can
replicate intracellularly and the IBC defect can be rescued by coinoculation with WT UTI89, which results in mixed strain, nonclonal, IBCs [52].
We primed mice with these strains and superinfected one hpi
with WT UTI89 and assessed bacteriuria at days 1, 7, 14, and 21
and enumerated bladder titers at 28 dpi. Mice were designated as
having chronic cystitis if they had urine bacterial titers greater than
104 CFU/ml at each time point and bladder titers greater than
104 CFU at sacrifice [37]. We found that the FimH::A27V/
V163A allele was incapable of priming the bladder for the
development of chronic cystitis (p,0.05 relative to WT superinfection). In contrast, FimH::A62S did not significantly differ from
PBS or WT superinfection; therefore, it may be capable of
priming, though to a lesser degree. UTI89DompA and UTI89Dkps
were both able to prime the bladder for enhanced chronic cystitis
relative to PBS when superinfected one hpi with WT UTI89 (p,
0.05 and p,0.01 respectively; Fig. 1C). We also primed with heatkilled UTI89 and found that live, but not heat killed, UTI89 were
capable of priming the bladder indicating that bacterial products
such as LPS were insufficient (Fig. 1B). These data indicate that
live and invasive UTI89 capable of at least some degree of
intracellular replication are required for the priming to enhance
the incidence of chronic cystitis upon superinfection of UTI89.
Taken together these data suggest that priming begins during
invasion and early IBC formation.

UPEC hemolysin and caspase 1/11 activation are
essential
One of the most potent host defenses to eliminate adherent and
invaded UPEC is superficial facet cell exfoliation [29]. The process
of exfoliation is activated in part by the bacterial expression of
hemolysin (HlyA) [53](Nagamatsu et al. in review). UTI89DcpxR
overexpresses HlyA, leading to exfoliation and attenuation in our
murine model of cystitis (Nagamatsu et al. in review). The
UTI89DcpxRDhlyA double mutant was not attenuated, suggesting
that the in vivo defect was due to increased hemolysin expression
(Nagamatsu et al. in review). The ability of UPEC to rapidly build
up in numbers in the form of IBCs and then disperse to
neighboring cells may be part of a mechanism to subvert an
exfoliation response. Thus, fine-tuning the expression of HlyA
during acute bladder infection may serve to maximize UPEC
persistence and give UPEC a fitness edge against the host innate
PLOS Pathogens | www.plospathogens.org
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Fig. 2. Role of caspase 1/11 and exfoliation in C3H/HeN superinfections. A) Inoculation protocol shown for caspase inhibition studies of
panel B. B) Four-week total bladder titer based on inhibitor or vehicle. C) Mice were inoculated with PBS, UTI89 or the indicated dose of protamine
sulfate in 50 mL PBS and inoculated one hour later with UTI89. Urine was collected weekly and overall bladder titers are shown at four weeks. Panel B
represents 5 experiments with n = 5–10 mice per group. Panel C represents 2 experiments with n = 5–10 mice per group. B–C) Observations in red
indicate resolved infection. Percent of mice with persistent bacteriuria and chronic cystitis is shown at the top of each column. For Panel B and C, a
Fisher’s Exact Test was used to determine significance between proportions of mice experiencing chronic cystitis. Mann-Whitney U Test was used to
compare median CFU values in Panel B.
doi:10.1371/journal.ppat.1004599.g002

four weeks compared to 0% in the singly infected group (Fig. 3A).
Kidney titers were also increased in the mice with persistent
bacteriuria, but we did not observe a significant increase in the
proportion of mice with kidney infection greater than 104 CFU
(Fig. 3B). These data suggest that at 24 hours after infection the
bladders of C57BL/6J mice were primed to develop chronic
cystitis upon superinfection. We investigated whether an ascending
kidney infection plays a role in predisposing these mice to chronic
cystitis by inoculating PBS into the bladder, either 24 hours before
or after infection with UTI89, to stimulate a bladder and ureter
stretch response or potentially increase reflux of bacteria into the
kidneys, respectively. We determined the percentage of mice with
persistent bacteriuria and those with bladder and kidney titers
greater than 104 CFU at sacrifice (Table 1). We found in all
conditions that persistent bacteriuria was a 100% predictor of
kidney titers.104 CFU at four wpi. Persistent bacteriuria also
predicted bladder titers greater than 104 CFU at four wpi in
C57BL/6J mice superinfected 24 hpi with UTI89. For the group

Superinfection leads to chronic cystitis in a resistant
mouse strain
C57BL/6J mice typically rapidly resolve bacteriuria and are
resistant to chronic cystitis upon single inoculation with UPEC
[37,38]. Five to ten percent of the time after inoculation with
UTI89, C57BL/6J mice experience persistent bacteriuria, but this
is generally due to kidney infection without concomitant high titer
bladder infection [37,41]. This degree of kidney infection is not
infectious dose dependent and therefore likely due to ureteric
reflux of the bacteria during experimental inoculation [37]. We
investigated whether superinfecting C57BL/6J mice during acute
infection would stimulate an immune response leading to chronic
cystitis. We inoculated bladders with PBS or 107 CFU of UTI89
followed by superinfection with UTI89 1, 6, 24, 48 hours or one
week after initial infection and collected urine at days 1, 7, 14, and
21 dpi followed by enumeration of bladder and kidney titers at
28 dpi (Fig. 3). A 24 hpi superinfection resulted in 35% of mice
sustaining persistent bacteriuria with bladder titers .104 CFU at
PLOS Pathogens | www.plospathogens.org
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of mice inoculated with PBS before the initial UTI89 infection,
persistent bacteriuria did not correlate with high bladder titers
suggesting these bacteria were only replicating in the kidneys.
Serially infecting with two inocula of UTI89 trended towards
increased persistent bacteriuria and chronic cystitis compared to
the group inoculated with UTI89 followed by PBS at 24 hpi
(P = 0.066; Table 1 and Fig. 4A). Kidney titers of UTI89
superinfected mice were significantly higher than when PBS was
used to prime or superinfect perhaps suggesting that repeat
infection may also increase susceptibility to pyelonephritis
(Fig. 4B). Thus, a 24 hpi superinfection of WT UTI89 led to
increased rates of persistent bacteriuria and chronic cystitis;
however, bladder/ureter stretch or kidney ascension at 24 hpi may
contribute to this increase.
C3H/HeN mice that progress to chronic cystitis upon single
inoculation can be predicted by elevated serum levels of IL-5, IL6, KC, and G-CSF at 24 hpi [37]. We hypothesized that similar
elevations would predict sensitization to chronic cystitis in
C57BL6/J mice if they were subsequently superinfected. Thus,
we determined levels of 23 serum cytokines from C57BL/6J mice
24 hrs after initial inoculation with PBS or UTI89 prior to
superinfection. We then superinfected a subset of the mice initially
infected with UTI89 (superinfection in Fig. 5) leaving the other

mice untouched (UTI89 group). All mice were evaluated with
urine titers over 28 d and sacrificed to enumerate bladder titers.
We stratified the superinfected mice based on outcome four weeks
later as determined by persistent bacteriuria and chronic cystitis.
We found elevations of serum KC (Fig. 5A), IL-6 (Fig. 5B), and GCSF (Fig. 5C) in mice that progressed to chronic cystitis relative to
those that resolved infection or were mock-infected with PBS.
Therefore, higher levels of these cytokines correlate with chronic
cystitis that develops later if mice are superinfected. At the time we
obtained serum, the single infection and superinfection groups
were identical, and no statistical differences existed among them.
These data demonstrate that a subset of C57BL/6J mice respond
to an initial infection in a way that results in higher specific serum
cytokine levels and primes them to develop chronic cystitis if an
additional insult is delivered 24 hpi.

Response to infection differs between C3H/HeN and
C57BL/6J
During chronic cystitis of singly-infected C3H/HeN mice, the
bladder epithelium is hyperplastic and normal terminal differentiation of the superficial facet cell layer, including the expression of
surface uroplakins, does not occur [37]. In this environment, the
bacteria are able to persist extracellularly by an unknown

Fig. 3. C57BL/6J mice are susceptible to chronic cystitis when superinfected 24 hpi. A–B) Mice were transurethrally infected with PBS or
UTI89 and re-infected at the indicated timepoints with UTI89. Urine was tracked weekly and four-week total bladder (A) and kidney pair (B) titer is
displayed. N = 2–4 experiments with 4–5 mice per group. Statistical differences determined by Fisher’s Exact test.
doi:10.1371/journal.ppat.1004599.g003
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All mice infected 24 hours after initial infection.
Defined as.104 CFU/mL bacteria in clean catch urine throughout four-week infection.
c
Median values listed.
d
Bladders of 20 mice were used for imaging purposes so no titers were available.
e
PPV is the positive predictive value of persistent bacteriuria predicting bladder/kidney titer greater than 104 CFU. NPV is the negative predictive value of resolved bacteriuria predicting bladder/kidney titer less than 104 CFU.
doi:10.1371/journal.ppat.1004599.t001

mechanism. To assess this, we conducted scanning electron
microscopy analysis on bladder tissue harvested at four wpi and
found that bacteria replicate in the presence of ongoing epithelial
exfoliation and neutrophil influx in chronic cystitis of both C3H/
HeN and C57BL/6J mice (S1A–D Fig.). This analysis supports
previous experiments that have shown that during chronic cystitis
the majority of bacteria are extracellular, replicating in the urine
or adherent to underlying transitional epithelial cells [24,37]. The
mechanism by which bacteria adhere in the absence of uroplakins
has not been demonstrated in vivo, but in vitro studies have shown
that FimH binds integrins and other host proteins such as TLR4
[30,58,59]. Alternatively additional adhesive factors such as other
CUP pili may play a role. Interestingly, during chronic cystitis,
neutrophils, which we observed to be actively engulfing bacteria,
are insufficient for clearing infection; however, the reason for this
is unclear. Mature superficial facet cells could not be discerned at
this time point, but were present in mock-infected mice (S1E Fig.).
Patients with persistent bacteriuria or rUTI have been reported to
have similar histopathology [42]. In order to identify the bladder
micro-environment in which UPEC replicate during chronic
cystitis, we conducted microarray analysis on RNA extracted from
bladders four wpi. C3H/HeN mice were singly-infected and
C57BL/6J mice were superinfected to develop chronic cystitis.
Mice from each strain inoculated with PBS were used as controls.
Depicted in Fig. 6 are the expression profiles relative to the global
average with green indicating increased expression and red
denoting decreased. C3H/HeN mice experiencing chronic cystitis
had a dramatically different expression profile from resolved and
mock-infected mice (Fig. 6A). Uroplakins were among the most
downregulated genes during chronic cystitis in both mouse
models, consistent with the lack of terminally differentiated
superficial facet cells (S1 Fig.). Eleven of the 20 (55%) most
upregulated genes during chronic cystitis were the same in both
mouse strains (S1 Table). The functional categorization revealed
that most of the up-regulated genes function in inflammatory
response, cytokine release, and ion binding [60–62]. Of interest
among these genes in both of these mouse models is the
inflammasome-related cytokines IL-1. We have shown that UPEC
activate the caspase 4 murine homologue, caspase 11, during acute
infection in a hemolysin-dependent fashion (Nagamatsu et. al. in
review). Despite these similarities, interesting differences existed in
the ongoing inflammatory response in mice experiencing chronic
cystitis (S1 Table). In C57BL/6J mice, the inflammatory response
is immunoglobulin- and cytokine-mediated whereas in C3H/HeN
mice, we noted a remarkable absence of upregulated immunoglobulin genes. The increased expression of antimicrobial peptides
such as RegIIIc and the calgranulins (s100a8 and s100a9) is
interesting because this increased expression is not sufficient to
eliminate bacterial replication during chronic cystitis. Interestingly,
C3H/HeN mice that were mock infected exhibited a very similar
profile to mice that resolve infection (Fig. 6A). Contrary to C3H/
HeN mice, C57BL/6J mice that resolved infection differed
significantly from either chronic cystitis or mock infected mice,
suggesting an element of altered physiology and immunological
memory of the infection (Fig. 6B). This information supports
research that serially infecting mice that resolve infection makes
them less susceptible to recurrent infection [37,63]. What is
interesting here is that the mechanisms by which this occurs may
differ between mouse strains, and possibly by extension, women.

Discussion
We have developed models of bacterial superinfection of the
urinary tract, which may provide insight into the connection
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Fig. 4. UTI89 Superinfection of C57BL/6J mice increases bladder and kidney infection. A–B) mice were infected with PBS or UTI89 Kanr
and re-infected 24 hrs later with PBS or UTI89 Spectr. Urine was tracked over four weeks and total bladder (A) and kidney pair titer (B) is displayed.
Number above columns indicates number of mice with persistent bacteriuria with bladder (A) or kidney (B) titer.104 CFU. Data represents 3–8
experiments with n = 4–29 mice per group. Panels also include data reproduced from Fig. 3. Statistical differences determined by Fisher’s Exact test.
doi:10.1371/journal.ppat.1004599.g004

Frequent sexual intercourse is among the most important risk
factors for rUTI in young women [22]. Peri-urethral carriage of
the causal strain and sexual intercourse immediately precede the
development of a rUTI [5]. Sexual intercourse likely introduces
mixed populations of bacteria into the urinary tract, with E. coli
being the most common [18]. In this environment, UPEC invade
bladder tissue and replicate, forming IBCs and bacterial filaments,
which have been observed in human urine in 40% of patients
suffering acute UTI, 24–48 hours after reported sexual intercourse
[21]. These data may provide mechanistic insight as to the
frequent clinical observation that recent and frequent sexual
intercourse over a brief period of time leads to increased rates of
rUTI [23]. Furthermore, elevated levels of serum CSF1, CXCL-1,
and CXCL-8 in women with acute UTI were associated with a
higher rate of rUTI [45]. Using C3H/HeN and C57BL/6J mice,

between recent and frequent sexual intercourse and the susceptibility to the development of chronic UTI [5,22]. Our results
demonstrate that superinfection resulted in increased susceptibility
to chronic cystitis in both susceptible and resistant mouse genetic
backgrounds, but the time window for priming differed between
strains. We have previously shown that chronic cystitis predisposes
to severe rUTI upon a subsequent infection weeks to months after
clearance of the first infection with antibiotics [37]. Clinically,
millions of women take post-coital and prophylactic antibiotics so
as not to develop rUTI [64]. Therefore, if clinically applicable, our
results detailed here may partially explain why frequent sexual
intercourse is such a strong risk factor for UTI. The necessity of
prophylactic antibiotics could be obviated if the risk factors and
bacterial traits identified here can be altered in the clinical
population of women suffering chronic rUTIs.

Fig. 5. Serum cytokine signature of C57BL/6J mice with persistent bacteriuria. Serum was obtained 24 hrs after initial inoculation prior to
superinfection. Levels of 23 cytokines were determined and cytokines showing significant differences between resolved and chronic superinfected
mice are shown. Levels of KC (A), IL-6 (B), and G-CSF (C) shown in pg/mL. Data represent 4–6 experiments with n = 4–29 mice per group. Statistical
differences determined by One-Way ANOVA overall and Mann-Whitney U test for pairwise comparisons.
doi:10.1371/journal.ppat.1004599.g005

PLOS Pathogens | www.plospathogens.org

8

January 2015 | Volume 11 | Issue 1 | e1004599

Superinfection Enhances Severe Bladder Infection

Fig. 6. Microarray gene changes for C3H/HeN and C57BL/6J bladders. A) C3H/HeN heatmap analysis for mice that resolved infection,
experienced chronic cystitis, or were mock infected with PBS. B) C57BL/6J heatmap analysis for mice mice that resolved infection, experienced
chronic cystitis, or were mock infected with PBS. Depicted is a representative analysis of two biological and three technical replicates.
doi:10.1371/journal.ppat.1004599.g006

recurrent UTI. Further work to identify bacterial and host factors
that influence the balance between resolution and chronic
infection is required to lead to better treatments clinically. The
ability of UPEC to invade bladder tissue allows it to transcend
stringent bottlenecks during infection [24,25,27]. The ability to
replicate intracellularly also impacts the ability of a second
invading strain to proliferate in the bladder environment (Fig. 1B–
C). The molecular basis of bacterial colonization of the bladder
during chronic cystitis is an area of active investigation. Previously,
it has been shown that mannosides are effective in treating chronic
cystitis arguing that FimH-mediated binding plays an important
role [67]. It has recently been demonstrated that FimH variation
outside of the binding pocket affects protein conformation and
pathogenicity of UPEC [48]. This variation may impact bacterial
adherence and replication during chronic cystitis. Furthermore,
because invasion and intracellular replication appear to influence
the likelihood to develop chronic cystitis, treatments with soluble
compounds such as mannosides that block the ability of UPEC to
invade the tissue or compounds that might alter FimH conformation hold promise as effective means to prevent or treat rUTI [67–
70]. These analyses may allow us to identify high-risk patients for
more aggressive therapy and/or anti-virulence compounds to limit
this troubling disease.

we have shown that superinfection during the period of acute
infection dramatically increases the proportion of mice that
experience chronic cystitis with inoculations of 107 UPEC (Fig. 1A
and 3A). The bacterial characteristics responsible for frequent
recurrences are beginning to be assessed [65]. Hemolysin is
expressed by 50% of UPEC isolates, but is more likely to be
associated with symptomatic UTI [66]. It is possible that
hemolysin-mediated exfoliation and caspase 1/11 activation leads
to UTI-associated symptoms. In our studies, we found that an
increase in priming for chronic cystitis correlated with the bacterial
ability to invade and replicate within the bladder tissue (Fig. 1B–
C), and through hemolysin to activate caspase 1/11 leading to IL1 secretion and bacterial replication (Fig. 1D and 2B). Activation
of caspase 1/11 has been shown to contribute to epithelial cell
death in vitro and exfoliation in vivo in C3H/HeN mice,
suggesting that caspase-mediated exfoliation may expose the
underlying epithelium upon which UPEC replicates during
chronic cystitis (Nagamatsu et. al. in review). Inhibition of caspase
1/11 protected superinfected mice from chronic cystitis (Fig. 2),
suggesting a role for cytokines downstream of caspase activation
including IL-1a and IL-1b, identified in our microarray of fourweek bladders (Fig. 6; S1 Table). A microarray analysis revealed
that in C3H/HeN and C57BL/6J mice, 11/20 of the most
upregulated genes during chronic cystitis were the same.
Differences between the responses to infection in these mouse
strains may result from the dramatic increase in kidney infection or
QIR presence in C57BL/6J relative to C3H/HeN mice [37,40].
Further, this data supports the hypothesis that a muted inflammatory response to UPEC infection is more likely to lead to
resolution [26]. Also, our studies suggest that serum biomarkers
such as IL-6, KC, and G-CSF may predict a predisposition to
rUTI (Fig. 5) [37]. Recently, it was demonstrated that cytokines
involved in immune cell chemotaxis and maturation (the human
homolog of KC included) during acute UTI enhanced the
likelihood of developing rUTI [45].
We have created mouse models that have identified both
bacterial and host immune factors that may predispose women to
rUTI. Inhibiting caspase-mediated inflammation or downstream
effectors may serve to prevent a UTI from becoming a chronic or
PLOS Pathogens | www.plospathogens.org

Materials and Methods
Bacterial strains
All WT bacterial strains utilized were derivatives of UTI89,
including tagged, isogenic UTI89 isolates, kanamycin resistant
UTI89 attHK022::COM-GFP, kanamycin resistant UTI89 with reintegrated UTI89 FimH, spectinomycin resistant UTI89
attl::PSSH10-1, and chloramphenicol resistant UTI89
[24,47,71]. FimH mutant strains, DompA, Dkps, DhlyA, DcpxR
were all previously published [47,51,52](Nagamatsu et al. in
review).

Mouse infections
Bacteria for infection were prepared as previously described
[72]. Six to seven week old female C3H/HeN (Harlan) or C57BL/
9
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6J (Jackson) were transurethrally infected with a 50 mL suspension
containing 56106–26107 CFU of UTI89 or relevant mutant in
PBS under 3% isofluorane. Protamine Sulfate (Sigma) was
dissolved in PBS and caspase 1/11 inhibitor Ac-YVAD-CMK
(BACHEM) was dissolved in DMSO and transurethrally inoculated into the bladder. At indicated timepoints after infection, mice
were anesthetized and infected again. Venous blood was obtained
at 24 hpi, just prior to re-infection, by submandibular puncture
and centrifuged at max speed at 4uC in Microtainer serum
separation tubes (BD) and stored at 220uC until use. Cytokine
expression was measured using the Bio-Plex multiplex cytokine
Group I bead kit array (Bio-Rad), which measures 23 cytokines.
Urine was obtained by gentle suprapubic pressure and serially
diluted and plated on appropriate antibiotic plates. Mice were
sacrificed by cervical dislocation under isofluorane anesthesia, and
their organs were aseptically removed. Chronic cystitis was
determined if animals had urine titers.104 CFU/mL at 1, 7,
14, 21 dpi and bladder titers.104 CFU at sacrifice at 28 dpi [37].
Animals that resolved infection and had a recurrence or had
resolved the infection with reservoir titers.104 CFU were marked
in red and considered to have resolved the chronic infection.
Organ titers shown are the total bacterial burden.

Scanning electron microscopy
Mice were infected as described above. Bladders were
aseptically harvested, bisected, and splayed. Bladders were fixed
in 2.0% glutaraldehyde in 0.1M sodium phosphate buffer
overnight. Bladders were then washed three times with 0.1M
sodium phosphate buffer and de-ionized water before being fixed
in 1.0% osmium tetroxide. Bladders were washed and then critical
point drying was performed with absolute ethanol and liquid
carbon dioxide. Sputter coating was performed with goldpalladium using a Tousimis Samsputter-2a. Images were obtained
on a Hitachi S-2600H operated at 20 kV accelerating voltage.

Statistical analysis
Datapoints below the limit of detection (LOD) were set to the
LOD for graphical representation and statistical analysis. For
cytokine data, values out of the range of the instrument were not
included for analysis. Fisher’s exact test was utilized to determine
differences between groups for rates of chronic cystitis. One-way
ANOVA was utilized to determine whether any cytokine
differences were apparent and pairwise assessment of median
values was determined by Mann-Whitney test. Unless otherwise
indicated, p,0.05 was considered significant. Analyses were
performed in Graphpad Prism 5.0.

Ethics statement
The Washington University Animal Studies Committee approved all mouse infections and procedures as part of protocol
number 20120216, which was approved 01/11/2013 and expires
01/11/2016. Overall care of the animals was consistent with The
guide for the Care and Use of Laboratory Animals from the
National Research Council and the USDA Animal Care Resource
Guide. Euthanasia procedures are consistent with the ‘‘AVMA
guidelines for the Euthanasia of Animals 2013 edition.’’

Supporting Information
S1 Fig. Bacteria replicate on the bladder surface during
chronic cystitis. Bladders of C3H/HeN and C57BL6 mice
were splayed four wpi and fixed in glutaraldehyde. A–B) Chronic
C3H/HeN bladders. C–D) Chronic C57BL/6J bladders. E) Mock
infected C57BL/6J bladder shown for comparison.
(TIF)
S1 Table Genes with highest fold change of chronic
cystitis versus resolved.
(PDF)

Microarray experiments
C3H/HeN or C57BL/6J mice were infected as discussed
above. After 28 days, animals that had developed chronic cystitis,
resolved the infection, or aged matched PBS controls were
sacrificed for RNA isolation. Upon sacrifice, 5 bladders from each
condition were immediately pooled and homogenized in Trizol for
RNA isolation according to the manufacture’s suggested protocol.
DNase treatment was performed to remove any contaminating
DNA before submission to the Genome Technology Access
Center for sample processing and hybridization on Affymetrix
Mouse Gene 1.0 chips in triplicate. Data was analyzed using the
Partek Genomics Suite. Gene lists were compiled using fdrANOVA analysis with a significance cut off of p,0.001.
Experiments were repeated twice with a representative analysis
shown. Microarray data are available in the ArrayExpress
database (www.ebi.ac.uk/arrayexpress) under accession number
E-MTAB-2930.
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